Full Text

Turn on search term navigation

© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Testicular torsion is a common emergency in adolescents, and can lead to severe ischemia reperfusion injury (IRI). LncRNA H19 has been shown to increase during ischemia, but its role in testicular IRI remains unknown. Focusing on this research gap, we utilized H19 biallelic mutant mice and Sertoli cell line (TM4) to construct in vivo and in vitro models of ischemia/reperfusion (I/R) and oxygen–glucose deprivation/reperfusion (OGD/R). Compared to WT I/R mice, H19−/− I/R mice showed milder tissue disorganization and cell loss, with a more intact blood–testis barrier (BTB). The cell viability decreased, ROS levels and apoptosis-related factors such as Bax/Bcl-2 increased in TM4 cells after OGD/R, whereas these changes were reversed when H19 was knocked down followed by OGD/R (si-H19+OGD/R). In contrast, over-expression of H19 in TM4 cells exacerbates OGD/R-induced cell apoptosis. Through in-depth analysis of KEGG-enriched pathways, the PI3K/AKT pathway was identified as a potential target of H19 modulation. Western blotting confirmed that, in OGD/R cells, elevated H19 levels were accompanied by the excessive AKT phosphorylation and the tight junction marker ZO-1 degradation; and in si-H19+OGD/R cells, the decreased AKT phosphorylation was recovered and the up-regulated ZO-1 expression was weakened simultaneously via using the AKT activator SC79. These results suggest that inhibiting H19 in OGD/R cells might preserve the integrity of the BTB by reversing the excessive phosphorylation of AKT. Moreover, H19 deficiency in si-H19+OGD/R cells alleviated the disturbances in glycolysis, fatty acid biosynthesis, and amino acid metabolism. Our study indicates that H19 might be a potential therapeutic target for clinic testicular I/R treatment.

Details

Title
Inhibition of LncRNA H19 Attenuates Testicular Torsion-Induced Apoptosis and Preserves Blood–Testis Barrier Integrity
Author
Cheng, Linxin 1 ; Yin, Zhibao 1 ; Liu, Han 1 ; Shi, Sijing 1 ; Lv, Limin 2 ; Wang, Yixi 3   VIAFID ORCID Logo  ; Zhou, Meng 1 ; Li, Meishuang 1 ; Guo, Tianxu 1 ; Guo, Xiyun 1 ; Yang, Guang 1 ; Ma, Junjun 1 ; Yu, Jinbo 1 ; Zhang, Yu 1 ; Duo, Shuguang 3 ; Zhao, Lihua 1 ; Li, Rongfeng 4   VIAFID ORCID Logo 

 Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University, Nanjing 211166, China; [email protected] (L.C.); [email protected] (Z.Y.); [email protected] (H.L.); [email protected] (S.S.); [email protected] (M.Z.); [email protected] (M.L.); [email protected] (T.G.); [email protected] (X.G.); [email protected] (G.Y.); [email protected] (J.M.); [email protected] (J.Y.); [email protected] (Y.Z.); State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China 
 Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing 211166, China; [email protected] 
 Laboratory Animal Center, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; [email protected] (Y.W.); [email protected] (S.D.) 
 Jiangsu Key Laboratory of Xenotransplantation, Nanjing Medical University, Nanjing 211166, China; [email protected] (L.C.); [email protected] (Z.Y.); [email protected] (H.L.); [email protected] (S.S.); [email protected] (M.Z.); [email protected] (M.L.); [email protected] (T.G.); [email protected] (X.G.); [email protected] (G.Y.); [email protected] (J.M.); [email protected] (J.Y.); [email protected] (Y.Z.); State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing 211166, China; [email protected] 
First page
2134
Publication year
2025
Publication date
2025
Publisher
MDPI AG
ISSN
16616596
e-ISSN
14220067
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3176406424
Copyright
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.